Jump Trading’s Celldex Therapeutics CLDX Stock Holding History

Jump Trading’s Portfolio CLDX Stock Details CLDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-125	Closed	-$24K	–	986
2014 Q3	$24K	Buy	+125	New	+$27.2K	﹤0.01%	984

Other funds holding CLDX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

CWAM

Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Jump Trading's CLDX Position: Q4 2014 in Review

Jump Trading sold out of Celldex Therapeutics (CLDX) in Q4 2014, closing a stake of 125 shares — an estimated $24K sold.

Jump Trading first reported a position in CLDX in Q3 2014 and held it in 1 quarter. The position peaked at $24K in Q3 2014. 163 funds tracked by Wall St. Rank hold CLDX as of Q4 2014.

Jump Trading reported no remaining Celldex Therapeutics position as of Q4 2014 after selling out during the quarter.
Jump Trading sold 125 Celldex Therapeutics shares in Q4 2014, an estimated $24K.
Jump Trading first reported a position in Celldex Therapeutics in Q3 2014 and held it in 1 quarter.
Jump Trading's Celldex Therapeutics position peaked at $24K in Q3 2014.
163 funds tracked by Wall St. Rank held Celldex Therapeutics as of Q4 2014.

Based on Jump Trading's 13F filing for Q4 2014, filed 17 Feb 2015.